Insider filing · BMRN
Gregory R Friberg
EVP, Chief R&D Officer
profile →
BioMarin Pharmaceutical Inc.
BMRN · Healthcare · 8 filings in 24 months
ticker →
Gregory R Friberg sold $382K of BioMarin Pharmaceutical (BMRN)
Executed Feb 26, disclosed Feb 26, the same day.
Value, as filed
$382K
6,326 sh × $60.38
Executed
Feb 26
the trade date, as filed
Disclosed
Feb 26
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GFGregory R Friberg (EVP, Chief R&D Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BioMarin Pharmaceutical Inc. (BMRN). The largest single filing was $382K of BMRN (6,326 sh × $60.38, as filed), executed Feb 26.
The name
BMRNHealthcare · BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening r…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Gregory R Friberg in BMRN
BMRNSALE
BioMarin Pharmaceutical Inc.
$177K3,281 sh × $53.85
Exec May 7
Filed May 11 · 5:30 PM ET